1Weisenthal LM,Lippmam ME.Clonogenic and nonclonogenic in vitro chemosensitivity assays. Cancer Treatment Reports . 1985
2Mosmann T.Rapid colorimetric assay for cellular growth and survival:application to proliferation and cytotoxicity assays. Journal of Immunological Methods . 1983
3Carmichael J,DeGraff G,Gazdar AF,et al.Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Research . 1987
4Alley MC,Scudiero DA,Monks A,et al.Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Research . 1988
5Hwang W-S,Chen L-M,Huang S-H,et al.Prediction of chemotherapy response in human leukemia using in vitro chemosensitivity test. Leukemia Research . 1993
6Preisler HD,Raza A,Larson R,et al.Some reasons for the lack of progress in the treatment of acute myelogenous leukemia: a reviow of three consecutive trials of the treatment of poor prognosis patients. Leukemia Research . 1991
3Perez R P, Handle L M, Hamilton T C. Potentiation of cisplatin cytotoxicity in human ovarian carcinoma cell lines by trifluoperazine,a calmodulin inhibitor[J]. Gynecol Oncol, 1992,46 (1): 82- 87.
4Szabo D,Szabo G J r,Ocsovszki I,et al. Anti-psychotic drugs reverse multidrug resistance of tumor cell lines and human AML cells ex-vivo[J]. Cancer Lett,1999,139(1) :115-119.
5Scheper R J,Broxterman H J,Scheffer G L,et al. Overexpression of a (Mr)110 000 vesicular protein in non-P-glycoproteinmediated multidrug resistance [J]. Cancer Res, 1993, 53 ( 7 ):1475-1479.
6Schneider E,Cowan K H,Bader H,et al. Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia[J]. Blood, 1995,85 (1): 186 - 193.
7Lee J S,Paull K,Alvarez M,et al. Rhodamine efflux patterns predict P-glycoprotein substrates in the national cancer institute drug screen[J]. Mol Pharmacol, 1994,46 (4): 627 - 638.
